European Case Law Identifier: | ECLI:EP:BA:2015:T206811.20150317 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 17 March 2015 | ||||||||
Case number: | T 2068/11 | ||||||||
Application number: | 05720034.7 | ||||||||
IPC class: | C12N 1/20 A23K 1/18 A23L 3/3463 A23L 3/3571 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | NOVEL LACTIC ACID BACTERIUM | ||||||||
Applicant name: | Biobalance Co., Ltd. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | All claim requests - sufficiency of disclosure (no), see points 5 and 6 | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t112068eu1.html
Date retrieved: 17 May 2021